bicalutamide

bicalutamide (APO-BICALUTAMIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

APO-BICALUTAMIDE is a marketed brand name for bicalutamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

bicalutamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.